• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis.难治疗部位银屑病(掌跖银屑病、甲银屑病、头皮银屑病和间擦部位银屑病)的证据及建议治疗方法
Indian J Dermatol. 2017 Mar-Apr;62(2):113-122. doi: 10.4103/ijd.IJD_539_16.
2
Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas.特殊部位银屑病的治疗:头皮、指甲和间擦部位。
Clin Dermatol. 2008 Sep-Oct;26(5):448-59. doi: 10.1016/j.clindermatol.2007.10.026.
3
Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails.未被诊断和治疗不足的银屑病:治疗影响头皮、面部、皱褶部位、生殖器、手部、足部和指甲的银屑病的细微差别。
Dermatol Ther. 2018 May;31(3):e12589. doi: 10.1111/dth.12589. Epub 2018 Mar 6.
4
Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas.治疗难治性部位银屑病的药物治疗方法。
Expert Opin Pharmacother. 2018 Apr;19(6):561-575. doi: 10.1080/14656566.2018.1448788. Epub 2018 Mar 22.
5
Evidence-based guidelines of the spanish psoriasis group on the use of biologic therapy in patients with psoriasis in difficult-to-treat sites (nails, scalp, palms, and soles).西班牙银屑病小组关于在治疗困难部位(指甲、头皮、手掌和脚底)的银屑病患者中使用生物疗法的循证指南。
Actas Dermosifiliogr. 2014 Dec;105(10):923-34. doi: 10.1016/j.ad.2014.02.015. Epub 2014 May 19.
6
Newer trends in the management of psoriasis at difficult to treat locations: scalp, palmoplantar disease and nails.治疗困难部位(头皮、掌跖部疾病和指甲)银屑病的新方法。
Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):634-44. doi: 10.4103/0378-6323.72455.
7
Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas.外用煤焦油泡沫剂治疗难治性部位银屑病的应用。
J Clin Aesthet Dermatol. 2010 Sep;3(9):37-40.
8
Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study.依法利珠单抗治疗头皮、掌跖及甲银屑病:一项为期24周的拉丁美洲研究结果
Arch Drug Inf. 2010 Mar;3(1):1-8. doi: 10.1111/j.1753-5174.2009.00025.x.
9
Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis.布罗达单抗在难治性银屑病中新兴治疗作用的叙述性综述
Dermatol Ther (Heidelb). 2022 Jun;12(6):1289-1302. doi: 10.1007/s13555-022-00746-6. Epub 2022 Jun 7.
10
Management of difficult to treat locations of psoriasis. Scalp, face, flexures, palm/soles and nails.银屑病难治部位的管理。头皮、面部、褶皱部位、手掌/足底及指甲。
Curr Probl Dermatol. 2009;38:160-171. doi: 10.1159/000232309. Epub 2009 Jul 28.

引用本文的文献

1
Epidemiology and clinical features of psoriasis in hard-to-treat body locations: a Chinese nationwide population-based study.难治性身体部位银屑病的流行病学及临床特征:一项基于全国人群的中国研究
BMC Immunol. 2025 Jul 3;26(1):45. doi: 10.1186/s12865-025-00724-5.
2
Phytotherapeutic Analysis of Chloroform-Based Fractions of and Extracts Reveals Potent Anti-Psoriatic Activity: An In Vitro and In Vivo Study.对[植物名称1]和[植物名称2]提取物的氯仿萃取物进行植物疗法分析,揭示其具有强大的抗银屑病活性:一项体外和体内研究。
Pharmaceuticals (Basel). 2025 Feb 22;18(3):304. doi: 10.3390/ph18030304.
3
Updates on Psoriasis in Special Areas.特殊部位银屑病的研究进展
J Clin Med. 2024 Dec 11;13(24):7549. doi: 10.3390/jcm13247549.
4
Fractional Carbon Dioxide Laser Combined with Secukinumab in the Treatment of Refractory Psoriasis Lesions on the Lower Legs.二氧化碳点阵激光联合司库奇尤单抗治疗小腿难治性银屑病皮损
Clin Cosmet Investig Dermatol. 2024 Dec 18;17:2953-2959. doi: 10.2147/CCID.S493967. eCollection 2024.
5
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study.司库奇尤单抗治疗中国中重度银屑病及特殊身体部位受累患者的疗效:一项随机、双盲、多中心3期研究的亚组分析
Adv Ther. 2025 Jan;42(1):146-163. doi: 10.1007/s12325-024-02976-w. Epub 2024 Sep 30.
6
Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study.司库奇尤单抗治疗累及特殊部位的中国中重度斑块状银屑病患者的有效性:一项前瞻性、多中心、观察性真实世界研究的亚组分析
Dermatol Ther (Heidelb). 2024 Apr;14(4):907-918. doi: 10.1007/s13555-024-01134-y. Epub 2024 Mar 27.
7
New-Onset and Exacerbation of Psoriasis following COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series.新型冠状病毒肺炎疫苗接种后银屑病的新发与加重:病例报告和病例系列的系统评价
Indian J Dermatol. 2023 Nov-Dec;68(6):724. doi: 10.4103/ijd.ijd_833_22. Epub 2024 Jan 9.
8
Assessment and Monitoring of Nail Psoriasis with Ultra-High Frequency Ultrasound: Preliminary Results.超高频率超声对甲银屑病的评估与监测:初步结果
Diagnostics (Basel). 2023 Aug 21;13(16):2716. doi: 10.3390/diagnostics13162716.
9
A case of scalp psoriasis resistant to ixekizumab treated with bimekizumab.一例对司库奇尤单抗耐药的头皮银屑病患者接受了比美吉珠单抗治疗。
JAAD Case Rep. 2023 Jul 3;38:123-126. doi: 10.1016/j.jdcr.2023.05.043. eCollection 2023 Aug.
10
Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO).生物制剂对中度至重度银屑病及特殊部位受累患者的比较疗效:健康结局银屑病观察研究(PSoHO)第12周结果
Front Med (Lausanne). 2023 Jun 29;10:1185523. doi: 10.3389/fmed.2023.1185523. eCollection 2023.

本文引用的文献

1
Inverse psoriasis treated with ustekinumab.用优特克单抗治疗反向性银屑病。
BMJ Case Rep. 2016 May 24;2016:bcr2016215019. doi: 10.1136/bcr-2016-215019.
2
Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis.阿普米司特,一种口服磷酸二酯酶-4 抑制剂,治疗掌跖银屑病:来自 PSOR-005 Ⅱ期和 Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis(ESTEEM)Ⅲ期临床试验的汇总分析结果,该试验入组了中重度银屑病患者。
J Am Acad Dermatol. 2016 Jul;75(1):99-105. doi: 10.1016/j.jaad.2016.02.1164. Epub 2016 Mar 24.
3
Topical treatments for scalp psoriasis.头皮银屑病的局部治疗
Cochrane Database Syst Rev. 2016 Feb 26;2(2):CD009687. doi: 10.1002/14651858.CD009687.pub2.
4
Severe Nail Fold Psoriasis Extending from Nail Psoriasis Resolved with Ustekinumab: Suggestion of a Cytokine Overflow Theory in the Nail Unit.从甲银屑病扩展而来的严重甲皱银屑病经乌司奴单抗治疗后缓解:甲单位细胞因子溢出理论的提示
Ann Dermatol. 2016 Feb;28(1):94-7. doi: 10.5021/ad.2016.28.1.94. Epub 2016 Jan 28.
5
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2).阿普米司特,一种口服磷酸二酯酶 4 抑制剂,用于治疗难治性指甲和头皮银屑病患者:两项 III 期随机对照试验(ESTEEM 1 和 ESTEEM 2)的结果。
J Am Acad Dermatol. 2016 Jan;74(1):134-42. doi: 10.1016/j.jaad.2015.09.001.
6
Broad-band UVB versus paint PUVA for palmoplantar psoriasis treatment.宽谱中波紫外线与外用补骨脂素加长波紫外线治疗掌跖银屑病的对比
J Dermatolog Treat. 2016;27(3):221-3. doi: 10.3109/09546634.2015.1093588. Epub 2015 Oct 20.
7
Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis.在一项针对慢性斑块型银屑病患者的 2 期临床试验中,使用依奇珠单抗改善头皮和指甲病变。
J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1763-70. doi: 10.1111/jdv.12996. Epub 2015 Feb 18.
8
Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation.甲银屑病治疗:全国银屑病基金会医学委员会的最佳实践推荐。
JAMA Dermatol. 2015 Jan;151(1):87-94. doi: 10.1001/jamadermatol.2014.2983.
9
Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study.阿达木单抗治疗中重度银屑病:BELIEVE研究中对头皮和指甲影响的亚组分析。
J Eur Acad Dermatol Venereol. 2015 Feb;29(2):353-360. doi: 10.1111/jdv.12553. Epub 2014 May 21.
10
Dermatological exposure to coal tar and bladder cancer risk: a case-control study.皮肤接触煤焦油与膀胱癌风险:一项病例对照研究。
Urol Oncol. 2015 Jan;33(1):20.e19-20.e22. doi: 10.1016/j.urolonc.2013.12.006. Epub 2014 Mar 12.

难治疗部位银屑病(掌跖银屑病、甲银屑病、头皮银屑病和间擦部位银屑病)的证据及建议治疗方法

Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis.

作者信息

Sarma Nilendu

机构信息

Department of Dermatology, Dr B. C. Roy Post Graduate Institute of Pediatric Sciences, Kolkata, West Bengal, India.

出版信息

Indian J Dermatol. 2017 Mar-Apr;62(2):113-122. doi: 10.4103/ijd.IJD_539_16.

DOI:10.4103/ijd.IJD_539_16
PMID:28400628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5363132/
Abstract

Psoriasis is resistant to treatment and it shows frequent relapse; systemic treatment is often associated with toxicities, and long-term safety data are lacking for most of the newer drugs like biologics. Moreover, some body areas such as hands, feet, intertriginous areas, scalp, and nails are even more resistant. Frequently, systemic treatments are necessary considering the higher psychological impact on the patient. There is a lack of agreement on the best therapeutic modalities in the management of psoriasis involving difficult-to-treat locations. At present, there are no Indian guidelines for these conditions. Available literature has been reviewed extensively on the treatment of psoriasis involving difficult-to-treat locations; level of evidence has been evaluated as per the Oxford Centre for Evidence-Based Medicine 2011 guideline, and therapeutic suggestions have been developed. Best care has been employed to consider socioeconomic, cultural, genetic, and ethnic factors to prepare a therapeutic suggestion that is appropriate and logical to be used among Indian population and people of similar ethnic and socioeconomic background.

摘要

银屑病治疗困难且易复发;全身治疗常伴有毒性,大多数新型药物如生物制剂缺乏长期安全性数据。此外,一些身体部位如手部、足部、褶皱部位、头皮和指甲对治疗更具抗性。通常,考虑到对患者更高的心理影响,全身治疗是必要的。在银屑病累及难治部位的管理中,对于最佳治疗方式缺乏共识。目前,印度尚无针对这些情况的指南。已广泛回顾了关于银屑病累及难治部位治疗的现有文献;根据牛津循证医学中心2011年指南评估了证据水平,并制定了治疗建议。已尽最大努力考虑社会经济、文化、遗传和种族因素,以制定出适合印度人群以及具有相似种族和社会经济背景人群使用的合理治疗建议。